{"id":11366,"date":"2018-07-27T21:46:58","date_gmt":"2018-07-28T01:46:58","guid":{"rendered":"https:\/\/clone.arsacs.com\/optimization-of-active-molecules-towards-a-pre-clinical-in-vivo-proof-of-mechanism-of-arsacs-phenotype-reversal-dr-michel-bouvier\/"},"modified":"2026-03-16T18:10:01","modified_gmt":"2026-03-16T22:10:01","slug":"optimization-of-active-molecules-towards-a-pre-clinical-in-vivo-proof-of-mechanism-of-arsacs-phenotype-reversal-dr-michel-bouvier-2","status":"publish","type":"post","link":"https:\/\/arsacs.com\/fr\/optimization-of-active-molecules-towards-a-pre-clinical-in-vivo-proof-of-mechanism-of-arsacs-phenotype-reversal-dr-michel-bouvier-2\/","title":{"rendered":"Optimisation des mol\u00e9cules actives en vue d\u2019une validation pr\u00e9clinique in vivo du m\u00e9canisme d\u2019inversion du ph\u00e9notype de l\u2019ARSACS \u2013 Dr Michel Bouvier"},"content":{"rendered":"<p class=\"wp-block-paragraph\">The goal is to develop small molecules that reverse the cellular phenotype of ARSACS into a drug that would stop the progression of the disease and\/or lead to clinical improvement.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Grant: $160,000<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Contact<\/p>\n\n\n\n<div class=\"wp-block-image\"><figure class=\"alignleft\"><img decoding=\"async\" src=\"https:\/\/arsacs.com\/wp-content\/uploads\/2021\/02\/Michel_Bouvier-1-150x150-2.jpg\" alt=\"\" class=\"wp-image-3353\"\/><\/figure><\/div>\n\n\n\n<p class=\"wp-block-paragraph\">Dr.Michel Bouvier, Institute for Research in Immunology and Cancer (IRIC)<br>IRIC | Universit\u00e9 de Montr\u00e9al C.P. 6128, succursale Centre-ville, Montr\u00e9al (Qu\u00e9bec) H3C 3J7<br>Tel: (514)-343-6319 ; Email: michel.bouvier@umontreal.ca<\/p>","protected":false},"excerpt":{"rendered":"<p>The goal is to develop small molecules that reverse the cellular phenotype of ARSACS into a drug that would stop the progression of the disease and\/or lead to clinical improvement. Grant: $160,000 Contact Dr.Michel Bouvier, Institute for Research in Immunology and Cancer (IRIC)IRIC | Universit\u00e9 de Montr\u00e9al C.P. 6128, succursale Centre-ville, Montr\u00e9al (Qu\u00e9bec) H3C 3J7Tel: [&#8230;]<\/p>\n","protected":false},"author":3,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[8],"tags":[],"class_list":["post-11366","post","type-post","status-publish","format-standard","hentry","category-research-2019"],"_links":{"self":[{"href":"https:\/\/arsacs.com\/fr\/wp-json\/wp\/v2\/posts\/11366","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/arsacs.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/arsacs.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/arsacs.com\/fr\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/arsacs.com\/fr\/wp-json\/wp\/v2\/comments?post=11366"}],"version-history":[{"count":3,"href":"https:\/\/arsacs.com\/fr\/wp-json\/wp\/v2\/posts\/11366\/revisions"}],"predecessor-version":[{"id":24412,"href":"https:\/\/arsacs.com\/fr\/wp-json\/wp\/v2\/posts\/11366\/revisions\/24412"}],"wp:attachment":[{"href":"https:\/\/arsacs.com\/fr\/wp-json\/wp\/v2\/media?parent=11366"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/arsacs.com\/fr\/wp-json\/wp\/v2\/categories?post=11366"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/arsacs.com\/fr\/wp-json\/wp\/v2\/tags?post=11366"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}